The DOI matches its OpenAlex record; 5 of the 5 references it cites were found in a registry or an index.
Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf
Open accessAbstract
Isoprenylcysteine carboxyl methyltransferase (Icmt) methylates the carboxyl-terminal isoprenylcysteine of CAAX proteins (e.g., Ras and Rho proteins). In the case of the Ras proteins, carboxyl methylation is important for targeting of the proteins to the plasma membrane. We hypothesized that a knockout of Icmt would reduce the ability of cells to be transformed by K-Ras. Fibroblasts harboring a floxed Icmt allele and expressing activated K-Ras (K-Ras-Icmt(flx/flx)) were treated with Cre-adenovirus, producing K-Ras-Icmt(Delta/Delta) fibroblasts. Inactivation of Icmt inhibited cell growth and K-Ras-induced oncogenic transformation, both in soft agar assays and in a nude mice model. The inactivation of Icmt did not affect growth factor-stimulated phosphorylation of Erk1/2 or Akt1. However, levels of RhoA were greatly reduced as a consequence of accelerated protein turnover. In addition, there was a large Ras/Erk1/2-dependent increase in p21(Cip1), which was probably a consequence of the reduced levels of RhoA. Deletion of p21(Cip1) restored the ability of K-Ras-Icmt(Delta/Delta) fibroblasts to grow in soft agar. The effect of inactivating Icmt was not limited to the inhibition of K-Ras-induced transformation: inactivation of Icmt blocked transformation by an oncogenic form of B-Raf (V599E). These studies identify Icmt as a potential target for reducing the growth of K-Ras- and B-Raf-induced malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 2×
“p21Cip1 levels are upregulated by overexpression of activated Ras, but this Ras-induced upregulation can be antagonized by RhoA (32, 34).”
Ras signalling on the endoplasmic reticulum and the Golgi
Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B., Silletti, J., Wiener, H., Johnson, R. L., Cox, A. D., & Philips, M. R. (2002) · Nature Cell Biology · doi:10.1038/ncb783 · Cited by 594 · cited 1×
“The Journal of Clinical Investigation | February 2004 | Volume 113 | Number 4 549 Golgi or ER was able to recruit Raf-1, activate the Erk pathway, and transform fibroblasts (37).”
Rho family proteins and Ras transformation: the RHOad less traveled gets congested
Zohn, I. M., Campbell, S. L., Khosravi-Far, R., Rossman, K. L., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202181 · Cited by 352
Research works printed but not linked: 38
- 10.1074/jbc.271.10.5289 · DOI · Paper page
- 10.1126/science.275.5307.1796 · DOI · Paper page
- 10.1074/jbc.273.24.15030 · DOI · Paper page
- 10.1073/pnas.87.24.9665 · DOI
- 10.1016/0092-8674(90)90242-7 · DOI · Paper page
- Bos, 1989, Cancer Res., 49, 4682
- 10.1038/nrc969 · DOI · Paper page
- 10.1073/pnas.89.14.6403 · DOI · Paper page
- 10.1038/nm0895-792 · DOI · Paper page
- Omer, 2000, Cancer Res., 60, 2680
- 10.1006/excr.2000.5076 · DOI
- 10.1038/sj.onc.1204146 · DOI · Paper page
- 10.2165/00003495-200161060-00002 · DOI
- 10.1016/S1367-5931(97)80010-5 · DOI
- Oliff, 1999, Biochim. Biophys. Acta., 1423, C19
- 10.1016/0968-0004(93)90072-U · DOI · Paper page
- 10.1073/pnas.93.9.4454 · DOI · Paper page
- 10.1074/jbc.272.22.14459 · DOI · Paper page
- 10.1074/jbc.274.13.8383 · DOI · Paper page
- 10.1128/MCB.22.1.171-181.2002 · DOI
- 10.1074/jbc.C000831200 · DOI · Paper page
- 10.1053/gast.2002.34279 · DOI
- 10.1074/jbc.C000079200 · DOI · Paper page
- 10.1126/science.7624797 · DOI · Paper page
- 10.1083/jcb.17.2.299 · DOI · Paper page
- Kelekar, 1986, Mol. Cell. Biol., 6, 7, 10.1128/MCB.6.1.7 · DOI
- 10.1126/science.7660125 · DOI · Paper page
- Webber, 1994, Am. J. Pathol., 145, 398
- 10.1038/28268 · DOI
- 10.1016/S0304-3835(01)00528-6 · DOI · Paper page
- 10.1093/emboj/20.4.755 · DOI · Paper page
- 10.1038/28425 · DOI · Paper page
- 10.1074/jbc.272.52.33175 · DOI
- 10.1074/jbc.M111369200 · DOI
- 10.1074/jbc.273.32.20243 · DOI
- 10.1074/jbc.272.43.27224 · DOI · Paper page
- 10.1073/pnas.89.14.6232 · DOI · Paper page
- 10.1101/gad.943001 · DOI · Paper page
Cited by
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
Ras history: The saga continues
Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706
Targeting protein prenylation for cancer therapy
Berndt, N., Hamilton, A. D., & Sebti, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3151 · Cited by 614
“Second, the carboxyl group in the now C-terminal prenylated cysteine is methylated by isoprenylcysteine carboxyl methyltransferase (ICMT”
Regulating the regulator: post-translational modification of RAS
Ahearn, I. M., Haigis, K., Bar-Sagi, D., & Philips, M. R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3255 · Cited by 557
Metadata
- Authors
- Bergö, M. O., Gavino, B. J., Hong, C., Beigneux, A. P., McMahon, M., Casey, P. J., & Young, S. G.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-02-15
- Volume
- 113
- Issue
- 4
- Pages
- 539-550
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2112532834
- Cited by
- 180
- References
- 5
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. https://app.cochat.ai/papers/10.1172/jci18829
- The paper
- Bergö, M. O., Gavino, B. J., Hong, C., Beigneux, A. P., McMahon, M., Casey, P. J., & Young, S. G. (2004). Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. Journal of Clinical Investigation. https://doi.org/10.1172/jci18829
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.